In RCC, kaempferol not only induces cell cycle arrest and apoptosis in RCC cells by targeting the EGFR/p38 pathway [35] but also inhibits RCC cell invasion and migration by targeting the AKT and FAK pathways [36], thereby effectively controlling the malignant progression of RCC. Here, PTK2 is linked to renal cell carcinoma.